Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1979 1
1980 1
1981 3
1982 3
1983 5
1984 5
1985 2
1986 8
1987 11
1988 16
1989 10
1990 7
1991 10
1992 11
1993 11
1994 11
1995 19
1996 17
1997 20
1998 25
1999 21
2000 37
2001 45
2002 57
2003 48
2004 77
2005 95
2006 93
2007 120
2008 138
2009 176
2010 201
2011 245
2012 319
2013 348
2014 381
2015 475
2016 512
2017 557
2018 672
2019 770
2020 891
2021 1050
2022 1234
2023 1245
2024 1341
2025 1708
2026 559

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,150 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.
Wang C, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH; China Venous Thromboembolism (VTE) Study Group. Wang C, et al. Among authors: cheng z. Chest. 2010 Feb;137(2):254-62. doi: 10.1378/chest.09-0765. Epub 2009 Sep 9. Chest. 2010. PMID: 19741062 Free PMC article. Clinical Trial.
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease (FLAVOUR II): a multicentre, randomised, non-inferiority trial.
Hu X, Zhang J, Yang S, Jiang J, Peng X, Lu D, Pan Y, Guo L, Li J, He W, Zhou H, Pu J, Huang J, Jiang F, Liu Q, Song D, Lu L, Cheng Z, Yang B, Ma J, Chen P, Li S, Meng Z, Tang L, Fan Y, Shin ES, Tu S, Nam CW, Fearon WF, Koo BK, Wang J; FLAVOUR II study group. Hu X, et al. Among authors: cheng z. Lancet. 2025 Apr 26;405(10488):1491-1504. doi: 10.1016/S0140-6736(25)00504-5. Epub 2025 Mar 30. Lancet. 2025. PMID: 40174597 Clinical Trial.
Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemia.
Cosgun KN, Jumaa H, Robinson ME, Cheng Z, Oulghazi S, Kume K, Fonseca Arce D, Agadzhanian N, Kistner KM, Leveille E, Drivet E, Yu F, Qian Z, Song JY, Chan WC, Xu L, Xiao G, Taketo MM, Kothari S, Davids MS, Schjerven H, Jellusova J, Müschen M. Cosgun KN, et al. Among authors: cheng z. Nat Cancer. 2026 Jan;7(1):150-168. doi: 10.1038/s43018-025-01093-z. Epub 2026 Jan 8. Nat Cancer. 2026. PMID: 41507538 Free PMC article.
State-specific enhancer landscapes govern microglial plasticity.
Hamagami N, Kapadia D, Barclay KM, Huang Y, Abduljawad N, Cheng Z, McLaughlin L, Singhania D, Ding X, Yang J, Sun Z, Karra V, Du S, Bayguinov P, Yu G, Li YE, Gabel HW, Li Q. Hamagami N, et al. Among authors: cheng z. Immunity. 2026 Feb 10;59(2):288-305.e11. doi: 10.1016/j.immuni.2025.11.023. Epub 2026 Jan 7. Immunity. 2026. PMID: 41506265 Free article.
Functional Nucleic Acids for Cell-Cell Interactions.
Zhang Z, Liu Y, Chen Q, Liu Y, Tan Y, Man Y, Cheng Z, Shao K, Wang Q, Du S, Lv Z, Liu Z. Zhang Z, et al. Among authors: cheng z. Small. 2026 Jan;22(6):e12348. doi: 10.1002/smll.202512348. Epub 2025 Dec 17. Small. 2026. PMID: 41406388 Review.
12,150 results
You have reached the last available page of results. Please see the User Guide for more information.